RHBDF1
Basic information
Region (hg38): 16:58059-76355
Previous symbols: [ "C16orf8" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RHBDF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 62 | 66 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 62 | 5 | 7 |
Variants in RHBDF1
This is a list of pathogenic ClinVar variants found in the RHBDF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-58426-G-A | not specified | Uncertain significance (Jun 12, 2023) | ||
16-58455-A-G | not specified | Uncertain significance (Dec 15, 2022) | ||
16-58513-G-A | not specified | Uncertain significance (Apr 04, 2023) | ||
16-58526-C-G | not specified | Uncertain significance (Jun 22, 2023) | ||
16-58642-G-T | Likely benign (Mar 01, 2023) | |||
16-58735-C-G | not specified | Uncertain significance (Dec 17, 2023) | ||
16-59015-C-T | not specified | Uncertain significance (Nov 17, 2023) | ||
16-59050-C-T | not specified | Uncertain significance (Aug 08, 2023) | ||
16-59290-G-A | Benign (May 18, 2018) | |||
16-59313-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
16-59477-C-T | not specified | Uncertain significance (Sep 26, 2022) | ||
16-59478-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
16-59759-C-T | not specified | Uncertain significance (May 31, 2023) | ||
16-59776-G-A | Likely benign (Jul 01, 2022) | |||
16-60236-C-G | not specified | Uncertain significance (Jan 03, 2024) | ||
16-60238-G-A | not specified | Uncertain significance (Aug 28, 2023) | ||
16-60265-G-A | not specified | Uncertain significance (Feb 26, 2024) | ||
16-60469-T-C | not specified | Uncertain significance (Mar 14, 2023) | ||
16-60484-G-A | Wolff-Parkinson-White pattern | Uncertain significance (Jul 14, 2017) | ||
16-60494-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
16-60503-G-A | not specified | Uncertain significance (Jan 19, 2024) | ||
16-60511-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
16-61128-C-G | not specified | Uncertain significance (Aug 28, 2023) | ||
16-61130-T-C | not specified | Uncertain significance (Oct 13, 2023) | ||
16-61159-G-C | not specified | Uncertain significance (Oct 12, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RHBDF1 | protein_coding | protein_coding | ENST00000262316 | 17 | 18297 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.41e-15 | 0.769 | 125685 | 0 | 63 | 125748 | 0.000251 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.45 | 481 | 579 | 0.830 | 0.0000416 | 5532 |
Missense in Polyphen | 181 | 227.53 | 0.79551 | 2178 | ||
Synonymous | -0.0322 | 243 | 242 | 1.00 | 0.0000180 | 1703 |
Loss of Function | 1.89 | 29 | 42.3 | 0.686 | 0.00000220 | 429 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000239 | 0.000239 |
Ashkenazi Jewish | 0.000595 | 0.000595 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000141 | 0.000139 |
European (Non-Finnish) | 0.000319 | 0.000308 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000328 | 0.000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Rhomboid protease-like protein which has no protease activity but regulates the secretion of several ligands of the epidermal growth factor receptor. Indirectly activates the epidermal growth factor receptor signaling pathway and may thereby regulate sleep, cell survival, proliferation and migration. {ECO:0000269|PubMed:15965977, ECO:0000269|PubMed:18524845, ECO:0000269|PubMed:18832597, ECO:0000269|PubMed:21439629}.;
Intolerance Scores
- loftool
- rvis_EVS
- -0.79
- rvis_percentile_EVS
- 12.6
Haploinsufficiency Scores
- pHI
- 0.225
- hipred
- Y
- hipred_score
- 0.697
- ghis
- 0.620
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rhbdf1
- Phenotype
- immune system phenotype; skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- proteolysis;cell population proliferation;protein transport;cell migration;regulation of epidermal growth factor receptor signaling pathway;regulation of protein secretion;negative regulation of protein secretion;regulation of proteasomal protein catabolic process
- Cellular component
- Golgi membrane;endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- serine-type endopeptidase activity;growth factor binding